Related Experiment Video
Updated: Oct 21, 2025

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
Moritz Reese1, Sameer A Dhayat2
1Department of General, Visceral and Transplant Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149, Muenster, Germany.
Abstract:
Pancreatic cancer has the worst prognosis among common tumors which is attributed to its aggressive phenotype, diagnosis at advanced, inoperable stages, and resistance to systemic therapy. Non-coding RNAs (ncRNAs) such as microRNAs, long non-coding RNAs, and circular RNAs have been established as important regulators of gene expression and their deregulation has been implicated in multiple diseases and foremost cancer. In the tumor microenvironment, non-coding RNAs can be distributed among cancer cells, stromal cells, and immune cells via small extracellular vesicles (sEVs), thereby facilitating intercellular communication and influencing major cancer hallmarks such as angiogenesis, evasion of the immune system, and metastatic dissemination. Furthermore, sEV-ncRNAs have shown promising potential as liquid biopsies with diagnostic and prognostic significance. In this review, we summarize the role of sEVs as carriers of ncRNAs and underlying molecular mechanisms in pancreatic cancer. Moreover, we review the potential of sEV-ncRNAs as biomarkers and highlight the suitability of sEVs as delivery vehicles for ncRNA-based cancer therapy.
Insights
Small extracellular vesicles (sEVs) carry non-coding RNAs (ncRNAs) in pancreatic cancer, influencing disease progression and offering potential as diagnostic biomarkers and therapeutic delivery vehicles.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Pancreatic cancer exhibits a poor prognosis due to aggressive traits, late diagnosis, and treatment resistance.
- Non-coding RNAs (ncRNAs) are key gene expression regulators, with their dysregulation linked to cancer development.
- Small extracellular vesicles (sEVs) mediate intercellular communication via ncRNA transfer within the tumor microenvironment.
Purpose of the Study:
- To review the role of sEVs as carriers of ncRNAs in pancreatic cancer.
- To explore the molecular mechanisms by which sEV-ncRNAs influence pancreatic cancer hallmarks.
- To discuss the potential of sEV-ncRNAs as diagnostic biomarkers and therapeutic delivery systems.
Main Methods:
- Literature review focusing on the role of ncRNAs and sEVs in pancreatic cancer.
- Analysis of molecular mechanisms underlying sEV-mediated ncRNA transfer.
- Evaluation of current research on sEV-ncRNAs for diagnostic and therapeutic applications.
Main Results:
- sEVs facilitate the intercellular transfer of ncRNAs (miRNAs, lncRNAs, circRNAs) in pancreatic cancer.
- sEV-ncRNAs contribute to cancer hallmarks including angiogenesis, immune evasion, and metastasis.
- sEV-ncRNAs show promise as non-invasive liquid biopsy biomarkers for diagnosis and prognosis.
Conclusions:
- sEVs are crucial mediators of ncRNA-based intercellular communication in pancreatic cancer.
- sEV-ncRNAs represent a significant area for biomarker discovery and development.
- sEVs hold potential as effective delivery vehicles for ncRNA-based pancreatic cancer therapies.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Insulin Secretory Vesicles
lncRNA - Long Non-coding RNAs